COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Assessment of energy and nutrient intake adequacy and dietary diversity of pregnant women in Abidjan
- Quantitative and qualitative assessment of food waste in rural markets in Morocco
- Nutritional and Bioactive Profile of Gitumon: An Indonesian Traditional Herbal Beverage
- Sports supplements: use, knowledge, and risks for Algerian athletes
- Sprouting bioprocess as a sustainable tool for enhancing durum wheat (Triticum durum) nutrients and bioactive compounds
- Impact of carob (Ceratonia Ciliqua L) pulp flour supplementation on probiotic viability, milk fermentation and antioxidant capacity during yogurt storage
- Supplementation species effect on the phenolic content and biological bioactivities of the decocted green tea
- Participatory cooking demonstrations for mothers improve feeding practices of young children in southern Benin
- Neurotoxic and neuromotor effects of cyanate, an oxidative byproduct of cyanide from linamarin in cassava: A systematic review
- Olive stone as a sustainable agricultural by-product: Valorization pathways and prospects in food and feed Industries
You may also start an advanced similarity search for this article.

NAJFNR is licensed under